Announcements Trials
Browse Landscape

Phase

Phase 2 106Phase 3 34Phase 1 24Phase 1/2 13Phase 2/3 5Phase NA 3Phase 4 2

Status

Terminated 1Completed 1

Sponsor Class

OTHER_GOV 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Carcinoma, Non-Small-Cell Lung 10Mesothelioma 3Lung Neoplasms 2Adenocarcinoma of Lung 2Adenocarcinoma 2Thoracic Neoplasms 1Non-Small Cell Lung Cancer Metastatic 1Lung Diseases 1Locally Advanced Malignant Neoplasm 1Advanced Non-squamous Non-small-cell Lung Cancer 1

Interventions

Propofol 6Carboplatin 5Sevoflurane 4Saline Solution 3Paclitaxel 3Nivolumab 3Erlotinib Hydrochloride 3Acetaminophen 3Pemetrexed 2Midazolam 2Lidocaine 2Isoflurane 2Docetaxel 2Desflurane 2Cryotherapy 2Bupivacaine 2Bronchoscopy 2Anesthesia, Inhalation 2trametinib 1sotorasib 1pegfilgrastim 1icotinib 1endostar protein 1durvalumab 1dabrafenib 1capmatinib 1camrelizumab 1beta Carotene 1atezolizumab 1alectinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Lung Neoplasms × Pemetrexed × Clear all
NCT05583188 2024-07-19

VIGOR

Galvanize Therapeutics, Inc.

Phase 4 Terminated
5 enrolled
Thoracic

Lung Diseases, Lung Neoplasms, Thoracic Neoplasms

NCT01442909 2011-09-29

Pemetrexed Followed by Docetaxel or in Reverse Sequence

Taipei Veterans General Hospital, Taiwan

Phase 4 Completed
44 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡